Nektar Therapeutics
NKTR
#5687
Rank
โ‚น103.97 B
Marketcap
โ‚น5,112
Share price
-1.37%
Change (1 day)
294.52%
Change (1 year)

Earnings for Nektar Therapeutics (NKTR)

Earnings in 2025 (TTM): -โ‚น9.86 Billion

According to Nektar Therapeutics 's latest financial reports the company's current earnings are โ‚น62.6 Million. In 2024 the company made an earning of -โ‚น10.71 Billion, an increase over its 2023 earnings that were of -โ‚น24.82 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nektar Therapeutics from 1994 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น9.86 Billion-8.01%
2024 -โ‚น10.71 Billion-56.85%
2023 -โ‚น24.82 Billion-24.31%
2022 -โ‚น32.79 Billion-30.25%
2021 -โ‚น47.01 Billion17.87%
2020 -โ‚น39.89 Billion0.88%
2019 -โ‚น39.54 Billion-164.46%
2018 โ‚น61.33 B-810.61%
2017 -โ‚น8.64 Billion-37.06%
2016 -โ‚น13.72 Billion89.22%
2015 -โ‚น7.25 Billion48.22%
2014 -โ‚น4.89 Billion-65.93%
2013 -โ‚น14.36 Billion-6.81%
2012 -โ‚น15.41 Billion28.95%
2011 -โ‚น11.95 Billion258.8%
2010 -โ‚น3.33 Billion-63.94%
2009 -โ‚น9.24 Billion-392.45%
2008 โ‚น3.15 B-211.74%
2007 -โ‚น2.83 Billion-79.57%
2006 -โ‚น13.83 Billion-16.9%
2005 -โ‚น16.65 Billion81.53%
2004 -โ‚น9.17 Billion54.19%
2003 -โ‚น5.95 Billion-33.87%
2002 -โ‚น9 Billion-9.6%
2001 -โ‚น9.95 Billion73.39%
2000 -โ‚น5.74 Billion108.9%
1999 -โ‚น2.75 Billion39.48%
1998 -โ‚น1.97 Billion60.02%
1997 -โ‚น1.24 Billion18.05%
1996 -โ‚น1.05 Billion31.82%
1995 -โ‚น0.8 Billion57.14%
1994 -โ‚น0.51 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
โ‚น740.61 B-7,345.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น1.064 T-10,516.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น2.074 T-20,393.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Richardson Electronics
RELL
โ‚น13.56 M-100.13%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น1.175 T-11,604.35%๐Ÿ‡ฌ๐Ÿ‡ง UK
Baxter
BAX
-โ‚น24.26 Billion 137.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
โ‚น36.43 B-456.48%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Johnson & Johnson
JNJ
โ‚น2.910 T-28,571.74%๐Ÿ‡บ๐Ÿ‡ธ USA